ACO Public Reporting

 

Central Maine ACO Public Reporting

ACO Name and Location

Central Maine ACO
300 Main Street
Lewiston, Maine 04240

ACO Primary Contact

Jeff Buck
207-795-2953
buckje2@cmhc.org

 

ACO participants

ACO Participants	ACO Participant in Joint Venture
Central Maine Clinical Associates Corporation	N
DFD Russell Medical Center Inc	N
Stephen R Barter MD	N
Freeport Medical Center, PA	N
Androscoggin Home Health Services, Inc.	N
Tri-County Mental Health Services	N
Rumford Hospital	N
Wilson Stream Family Practice LLC, PA	N
Parkview Medical Associates, PA	N
Central Maine Medical Center	N
Knapp Family Practice, Llc	N
Rumford Community Family Health Center Inc.	N
Bridgton Hospital	N
Lewiston Operations Llc (D/B/A Marshwood Center)	N

 

ACO governing body:

Member Last Name	Member First Name	Member Title/ Position	Member’s Voting Power: expressed as a percentage or number	Membership Type	ACO Participant Legal Business Name/DBA, if applicable
Alexander	John	President	0%	ACO Participant representative	Central Maine Medial Center
Brickman	Jeff		10%	ACO Participant representative	Rumford Hospital
Whitlock	John		10%	ACO Participant representative	Central Maine Medical Center
Wright	Peter		10%	ACO Participant representative	Bridgton Hospital
Salko	David		10%	ACO Participant representative	Central Maine Medical Center
Doyle	Jon		10%	Medicare beneficiary representative
Kane-Lewis	Laurie		10%	ACO Participant representative	DFD Russell Medical Center Inc.
Burke	Mike		10%	ACO Participant representative	Tri-County Mental Health Services
Cave	Cynthia		10%	ACO Participant representative	Lewiston Operations, Llc (D/B/A Marshwood Center)
Albert	Ken		10%	ACO Participant representative	Androscoggin  Home Health Services, Inc.
Knapp	Michelle		10%	ACO Participant representative	Knapp Family Practice, Llc

 

Key ACO clinical and administrative leadership:

ACO Executive: Jeff Buck
Medical Director: John Alexander, M.D.
Compliance Officer: Nicholas Snyder
Quality Assurance/Improvement Officer: Rebekah Dube, Pharm.D.

Associated committees and committee leadership:

Committee Name	Committee Leader Name and Position
Provider Advisory Group	John Alexander, MD; Chair
Ambulatory Quality Committee	Ambulatory Quality Committee

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangement
• Networks of individual practices of ACO professionals
• Partnerships or joint venture arrangements between hospitals and ACO professionals
• Hospital employing ACO professionals
• Critical Access Hospital (CAH) billing under Method II
• Federally Qualified Health Center (FQHC)
• Rural Health Clinic (RHC)

Shared Savings and Losses

Amount of Shared Savings/Losses:

• Third Agreement Period
  • Performance Year 2019, $0
• Second Agreement Period
  • Performance Year 2018, $0
  • Performance Year 2017, $0
  • Performance Year 2016, $0
• First Agreement Period
  • • Performance Year 2015, $0
    • Performance Year 2014, $0
    • Performance Year 2013, $0

Shared Savings Distribution:

• Third Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A%
    • Proportion invested in redesigned care processes/resources: N/A%
    • Proportion of distribution to ACO participants: N/A%
• Second Agreement Period
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2016
    • • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2015
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2014
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2013
      • • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2019 Quality Performance Results:

ACO #	Measure Name	Rate	ACO Mean
ACO-1	CAHPS: Getting Timely Care, Appointments, and Information	86.58	85.86
ACO-2	CAHPS: How Well Your Providers Communicate	94.36	94.11
ACO-3	CAHPS: Patients’ Rating of Provider	92.68	92.69
ACO-4	CAHPS: Access to Specialists	78.57	81.54
ACO-5	CAHPS: Health Promotion and Education	62.39	60.44
ACO-6	CAHPS: Shared Decision Making	57.56	62.78
ACO-7	CAHPS: Health Status/Functional Status	76.83	73.79
ACO-34	CAHPS: Stewardship of Patient Resources	25.00	26.17
ACO-45	CAHPS: Courteous and Helpful Office Staff	92.68	92.84
ACO-46	CAHPS: Care Coordination	85.14	86.89
ACO-8	Risk Standardized, All Condition Readmission	14.23	14.86
ACO-38	All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions	50.64	58.15
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	1.44	1.87
ACO-13	Falls: Screening for Future Fall Risk	81.05	84.04
ACO-14	Preventive Care and Screening: Influenza Immunization	76.23	74.77
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	93.10	78.04
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plan	86.78	70.40
ACO-19	Colorectal Cancer Screening	71.37	70.76
ACO-20	Breast Cancer Screening	71.77	73.84
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	92.89	82.17
ACO-27	Diabetes: Hemoglobin A1c Poor Control (>9%)	18.15	13.88
ACO-28	Controlling High Blood Pressure	84.27	75.04

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size.